Neslihan Yuksel-Catal

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 08, 2025
Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers.

Baris Sergi, Neslihan Yuksel-Catal, Selahattin Can Ozcan

Pageof 1

Frequent Collaborators

1 joint publications

Selahattin Can Ozcan

1 joint publications

Hamzah Syed

1 joint publications

Kirill Kiselyov

1 joint publications

Ceyda Acilan